Skip to main content

Table 4 Changes in “no” and “not sure” responses to PP cases after Phase 2 (final adjudication)

From: Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care – a collaborative study with experts from Diabetes Canada

Response After Phase 2

Total

Chapter 1. Glycemic management (n = 124)

Chapter 2. Dyslipidemia (n = 111)

Chapter 3. Blood pressure control (n = 135)

Chapter 4. Anti-platelet therapy (n = 11)

PP cases marked “no” in Phase 1

259

92

70

92

5

 “No” to “yes”

228

79

66

82

1

“No” to “not sure”

4

0

1

2

1

 Unchanged “no”

26

12

3

8

3

 Missing

1

1

0

0

0

PP cases marked “not sure” in Phase 1

135

39

33

46

17

“Not sure” to “yes”

110

33

31

41

5

“Not sure” to “no”

16

3

2

1

10

 Unchanged “not sure”

6

0

0

4

2

 Missing

3

3

0

0

0

  1. PP predicted positive